Evaluation status available after sign-in
About the journal
Thrombosis Update is an open-access journal published by Elsevier in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,230 USD. Declared review time at DOAJ: 25 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2666-5727
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,230 USD
- Articles in DOAJ
- 226
- Declared review time
- 25 weeks
- Declared peer-review model
- other
- Official website
- https://www.sciencedirect.com/journal/thrombosis-update
Index listings
- DOAJ · 2021-01-29
- Indexing
- DOAJ
- APC
- 2,230 USD
- Declared review time (DOAJ)
- 25 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
226
Most recent article
last month
Average review time (journal-declared via DOAJ)
25weeks
Works in OpenAlex
227
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
14
i10-index
26
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2021-01-29
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 96%
- ORCID iDs in current deposits
- 70%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity1
- Source type
- journal
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
LCC codes
RC666-701
Subject areas
- Venous Thromboembolism Diagnosis and Management
- Venous Thromboembolism Diagnosis and Management
- Venous Thromboembolism Diagnosis and Management
- Blood Coagulation and Thrombosis Mechanisms
- Atrial Fibrillation Management and Outcomes
- Atrial Fibrillation Management and Outcomes
- Atrial Fibrillation Management and Outcomes
- COVID-19 Clinical Research Studies
Show all subjects (75)
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Blood Coagulation and Thrombosis Mechanisms
- Blood Coagulation and Thrombosis Mechanisms
- Blood properties and coagulation
- Complement system in diseases
- Heparin-Induced Thrombocytopenia and Thrombosis
- Platelet Disorders and Treatments
- Heparin-Induced Thrombocytopenia and Thrombosis
- Acute Myocardial Infarction Research
- Acute Ischemic Stroke Management
- Acute Myocardial Infarction Research
- Cerebral Venous Sinus Thrombosis
- Platelet Disorders and Treatments
- Platelet Disorders and Treatments
- Acute Ischemic Stroke Management
- Acute Ischemic Stroke Management
- Central Venous Catheters and Hemodialysis
- Central Venous Catheters and Hemodialysis
- Complement system in diseases
- Complement system in diseases
- Heparin-Induced Thrombocytopenia and Thrombosis
- Blood properties and coagulation
- Hemophilia Treatment and Research
- Long-Term Effects of COVID-19
- Cardiac Arrhythmias and Treatments
- Long-Term Effects of COVID-19
- Cardiac Arrhythmias and Treatments
- Diagnosis and Treatment of Venous Diseases
- Hemophilia Treatment and Research
- Diagnosis and Treatment of Venous Diseases
- Blood properties and coagulation
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- COVID-19 and healthcare impacts
- Maternal and fetal healthcare
- Pregnancy and preeclampsia studies
- Inflammatory Biomarkers in Disease Prognosis
- Systemic Lupus Erythematosus Research
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Maternal and fetal healthcare
- COVID-19 and healthcare impacts
- Hemophilia Treatment and Research
- Pregnancy and preeclampsia studies
- Pregnancy and preeclampsia studies
- Renal Diseases and Glomerulopathies
- Blood Pressure and Hypertension Studies
- Renal Diseases and Glomerulopathies
- Blood Pressure and Hypertension Studies
- Cardiovascular and Diving-Related Complications
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Antiplatelet Therapy and Cardiovascular Diseases
- Systemic Lupus Erythematosus Research
- Cardiac tumors and thrombi
- Cardiac tumors and thrombi
- Systemic Lupus Erythematosus Research
- Antiplatelet Therapy and Cardiovascular Diseases
- COVID-19 and healthcare impacts
- Acute Myocardial Infarction Research
- Peripheral Artery Disease Management
- Long-Term Effects of COVID-19
- Hemoglobinopathies and Related Disorders
- Blood transfusion and management
- Vasculitis and related conditions
- Pharmacogenetics and Drug Metabolism
Keywords (DOAJ)
- vascular biology
- thrombosis
- hemostasis
- vascular disease
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ